Amylyx Pharmaceuticals shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Amylyx Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Amylyx Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Amylyx Pharmaceuticals by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $393k | 27k | 14.72 |
| 2023-09-30 | $489k | 27k | 18.31 |
| 2023-06-30 | $576k | 27k | 21.57 |
| 2023-03-31 | $784k | 27k | 29.34 |
| 2022-12-31 | $987k | 27k | 36.95 |
| 2022-09-30 | $548k | 20k | 28.16 |
| 2022-06-30 | $131k | 6.8k | 19.31 |
| 2022-03-31 | $87k | 6.8k | 12.85 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors